SCHEDULE 13G/A
Statement of Beneficial Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001172661-26-005056
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 7,225,439 | 7.94% |
| BAM GP LLC | 7,225,439 | 7.94% |
| Balyasny Asset Management Holdings LP | 7,225,439 | 7.94% |
| Dames GP LLC | 7,225,439 | 7.94% |
| Dmitry Balyasny | 7,225,439 | 7.94% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…